It’s that time of year again! ECCMID 2024 is here and many of ARLG’s top leaders and experts are featured, discussing the latest AR topics. Whether you plan to attend virtually or in person, use the table below to plan ahead to join your favorite sessions and posters.
Learn more and view OnDemand content at ECCMID.org
| Date | Time (CEST) | Location/Session | Number | Title | Short Title | Presenting Author | Authors |
|---|---|---|---|---|---|---|---|
| April 29, 2024 | 8:30 - 9:30 a.m. | Hall E/OS164 Late Breakers: Clinical Trials: antimicrobial resistant bacteria | 09258 | Dalbavancin is non-inferior to standard of care therapy for complicated Staphylococcus aureus bacteremia (SAB) | DOTS | N. Turner | Nicholas A. Turner, Toshimitsu Hamasaki, Scott Evans, Sarah B. Doernberg, Thomas P. Lodise, Heather King, Varduhi Ghazaryan, Sara E. Cosgrove, Timothy C. Jenkins, Catherine Liu, Shrabani Sharma, Smitha Zaharoff, Lana Wahid, Paul Cook, Issam Raad, Ray Hachem, Anne-Marie Chaftari, Matthew Sims, Carmen DeMarco, Loren G. Miller, Matthew W. McCarthy, Caryn G. Morse, Chris Lucasti, Graeme Forrest, Kartikeya Cherabuddi, Christopher Polk, Tasaduq Fazili, Mark E. Rupp, George R. Thompson, Kami Kim, Luke Strnad, Amanda E. Schnee, James A. McKinnell, Mayur Ramesh, Fernanda P. Silveira, Todd P. McCarty, Todd C. Lee, Emily G. McDonald, Kristopher Paolino, Katie Wiegand Meng, Alison Wall, Todd Riccobene, Rinal Patel, Urania Rappo, Henry F. Chambers, Vance G. Fowler, Jr., Thomas L. Holland on behalf of the Antibacterial Resistance Leadership Group |
| April 29, 2024 | 12:00 - 12:30 p.m. | Poster Area | P1829 | Black females hospitalised in the United States have worse outcomes after carbapenem-resistant Enterobacterales (CRE) bloodstream infection (BSI) | REPROCESS | F. Ruffin | Felicia Ruffin, Lizhao Ge, Lauren Komarow, Melinda Pettigrew, Vance G. Fowler, Jr., and David Van Duin |
| April 29, 2024 | 12:00 - 12:30 p.m. | Poster Area | P1812 | Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the Prospective Observational Pseudomonas (POP) study | POP-MDRO | L. Gottesdiener | Lee Gottesdiener, Yixuan Li, Kerryl Greenwood-Quaintance, Lauren Komarow, Cesar Arias, Eric Cober, Erica Herc, Thamer Alenazi, Keith Kaye, W. Charles Huskins, Jairo Figueroa, Samuel Vilchez, Bettina Fries, Marcel Leroi, Todd Mccarty, Maria Rioseco, Jose Munita, Martin Stryjewski, Jinnethe Reyes, Liang Chen, Barry Kreiswirth, Carol Hill, Keri Baum, Maria Virginia Villegas, David Paterson, Robert Bonomo, Henry Chambers, Vance Fowler, Robin Patel, Yohei Doi, David Van Duin, and Michael Satlin |